Potential target identified for migraine therapy

Researchers have identified the protein GLT-1 as the neurotransmitter glutamate transporter in the brain that is related to cortical spreading depression, a pathological condition that underlies migraines. The researchers found that mice lacking GLT-1, but not other glutamate receptors, were more susceptible to cortical spreading depression than were controls. GLT-1 might therefore be a potential target for migraine therapy.

from Latest Science News -- ScienceDaily https://ift.tt/2EbRR9P

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence